✦ LIBER ✦

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

✍ Scribed by Daniel J Drucker; John B Buse; Kristin Taylor; David M Kendall; Michael Trautmann; Dongliang Zhuang; Lisa Porter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exenatide once weekly versus liraglutide

✍ Buse, John B; Nauck, Michael; Forst, Thomas; Sheu, Wayne H-H; Shenouda, Sylvia K 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 389 KB

Once-weekly dulaglutide versus once-dail

✍ Dungan, Kathleen M; Povedano, Santiago Tofé; Forst, Thomas; González, José G Gon 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 535 KB

Once-weekly albiglutide versus once-dail

✍ Pratley, Richard E; Nauck, Michael A; Barnett, Anthony H; Feinglos, Mark N; Oval 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 288 KB

Exenatide once weekly versus insulin gla

✍ Diamant, Michaela; Van Gaal, Luc; Guerci, Bruno; Stranks, Stephen; Han, Jenny; M 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 442 KB

Liraglutide once a day versus exenatide

✍ John B Buse; Julio Rosenstock; Giorgio Sesti; Wolfgang E Schmidt; Eduard Montany 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 244 KB

PDB27 Projected Cost-Effectiveness of Ex

✍ Wilson, B.P.; Beaudet, A.; Caputo, J.; Timlin, L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB